biotech

biotech Articles

After scPhamaceuticals announced that it had received a Complete Response Letter from the FDA, its shares were absolutely crushed on Monday.
Sutro Biopharma made a huge gain to close out the week after the firm provided an update from its ongoing dose-escalation in its ovarian cancer trial.
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
Vanda Pharma shares jumped on Wednesday after the company announced an update from the FDA regarding its treatment for nighttime sleep disturbances associated with Smith-Magenis syndrome.
Moderna shares continued to run higher on Monday after the company announced an update for the primary efficacy analysis for its late-stage coronavirus vaccine trial.
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Shares of COVID-19 vaccine duo Pfizer and BioNTech made handy gains on Wednesday after they announced their late-stage coronavirus study had concluded.
Inovio Pharmaceuticals shares soared on Monday after the company provided an update for its coronavirus vaccine candidate.
Moderna reported a 95.4% effectiveness rate for its COVID-19 vaccine. This is the second vaccine to hit more than 90% efficacy in the past week.
Five Prime Therapeutics' shares more than tripled on Wednesday after the company announced positive topline results from its gastric cancer study.
Altimmune made a step forward on Tuesday with its vaccine candidate for COVID-19. Specifically, the firm entered into a manufacturing agreement the vaccine candidate.
24/7 Wall St. has tracked multiple analyst calls regarding the expected approval or nonapproval of aducanumab as the first viable treatment against Alzheimer's disease.
Pfizer and BioNTech stocks both exploded on Monday after these companies provided an update on their coronavirus vaccine.
Regeneron Pharma reported its third-quarter financial results before the markets opened on Thursday.